← Evidence map

ArticleCancer biomarkers : section A of Disease markers2022

CD133 is an independent predictive and prognostic marker in metastatic breast cancer.

Ahmed Mubarak Hefni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36120770